
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Radiation Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1564126
This article is part of the Research Topic Innovative Approaches in Precision Radiation Oncology View all 6 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
This retrospective study aimed to evaluate the treatment accuracy of linear accelerator-based fractionated stereotactic radiotherapy (FSRT) using single-isocenter multi-target (SIMT) in patients with multiple brain metastases. We explored the impact of rotational error on planning target volume (PTV) margins, providing clinical evidence for the selection of appropriate PTV margin values. A total of 161 patients with multiple brain metastases (733 treatments; actual clinical PTV margins: 1~2mm) were included. Theoretical PTV margins were calculated based on the Van Herk and Jenghwa Chang formulas. We analyzed the influence of the distance from each target to the treatment isocenter, rotational errors, and PTV margin on treatment outcomes. Additionally, individualized PTV margins for each patient were calculated using the Jenghwa Chang formula and patients were divided into subgroups according to a 2-mm threshold for further analysis.The mean residual translational setup errors ranged from -0.04~0.01mm, and rotational setup errors ranged from 0.15°~0.49°, both within acceptable limits. According to the Van Herk formula, required margins in posterior-anterior, superior-inferior, and right-left directions were 1.44mm, 1.68mm, and 1.78mm, respectively. By incorporating both translational and rotational errors using the Jenghwa Chang formula, the comprehensive margin ranged from 1.69~1.79mm (calculated based on the 95%CI of distances from targets to isocenter). Additionally, when the mean distance from all targets to their respective treatment isocenters was 30.62mm, the required margin calculated solely for translational errors using the Jenghwa Chang formula was 1.23mm; if rotational errors were neglected, target coverage probability would decrease from 95% to 73%. Further subgroup analysis showed that 25 patients whose individualized theoretical margins exceeded 2mm tended to experience worse outcomes compared to others, including intracranial local failure (32.00% vs. 22.29%, P=0.32), one-year local control (64.00% vs. 65.44%, P=0.89), and one-year intracranial progression-free survival (44.00% vs. 51.45%, P=0.85). However, these differences did not reach statistical significance. This study confirms that the SIMT technique ensures treatment accuracy for FSRT in multiple brain metastases. Rotational errors reduce dose coverage, and a minimum safety margin of 1.79mm is recommended to ensure tumor coverage and reduce local failure, providing a basis for future treatment optimization.
Keywords: single-isocenter multi-target, Fractionated stereotactic radiotherapy, volumetric modulated arc therapy, Multiple brain metastases, rotational errors, Planning Target Volume Margin Expansion
Received: 21 Jan 2025; Accepted: 03 Apr 2025.
Copyright: © 2025 Li, Hua, Dai, Chen, Zhang, Wang, Xu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yufeng Xu, Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, China
Tingting Wang, Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.